top border
top border
Featured Programs
Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology
Cancer is a complex disease characterized by uncontrolled cell growth and metastatic dissemination of tumor cells. View Now
Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma
Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma. View Now

 

Featured Video
Dr. Esteva on the Future of Biosimilars in Breast Cancer
Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now
Gina Columbus

Gina Columbus highlights the latest news in oncology in this week's OncLive News Network.

Publication Bottom Border
Border Publication
x